SXLV news

SPDR S&P U.S. Health Care Select Sector UCITS ETF · IE00BWBXM617

Showing news for XLV (The Health Care Select Sector SPDR Fund), a US-listed fund that is similar to SXLV. How we match funds

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
34.9% of XLV
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
26.5% of XLV
Benzinga · 29 Oct 2026, 03:07 UTC
Eli Lilly Shares Rise 1.89% After Hours - Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY)
16.5% of XLV
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
22.0% of XLV
Where to buy SXLV
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
22.3% of XLV
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
22.0% of XLV
Where to buy SXLV
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
16.5% of XLV
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
16.5% of XLV
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
16.5% of XLV
Benzinga · 28 Oct 2026, 10:04 UTC
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings - Eli Lilly (NYSE:LLY)
16.5% of XLV
Yahoo! Finance · 27 Oct 2026, 15:16 UTC
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
27.1% of XLV
Yahoo! Finance · 27 Oct 2026, 13:47 UTC
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
24.1% of XLV
www.theepochtimes.com · 28 Oct 2026, 00:00 UTC
Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk
16.5% of XLV
Business Insider · 28 Oct 2026, 00:00 UTC
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
16.5% of XLV
Yahoo! Finance · 27 Oct 2026, 23:28 UTC
$10,000 Invested in Eli Lilly 5 Years Ago Would Be Worth This Much Today
16.5% of XLV
The Boston Globe · 27 Oct 2026, 22:09 UTC
MGH, Brigham, other hospitals sue Eli Lilly, alleging 'extortion' in drug discount program
16.5% of XLV
Seeking Alpha · 27 Oct 2026, 22:08 UTC
Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick (NVO) | Seeking Alpha
16.5% of XLV
Investing.com · 27 Oct 2026, 20:47 UTC
Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit By Reuters
16.5% of XLV
Market Screener · 27 Oct 2026, 20:37 UTC
Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit
16.5% of XLV
Benzinga · 28 Oct 2026, 19:32 UTC
Traders Are Pricing a 7% Swing in Amazon Ahead of Earnings - Amazon.com (NASDAQ:AMZN), Intel (NASDAQ:INTC
7.6% of XLV